|
Clevidipine
|
丁酸氯維地平
|
167221-71-8
|
|
SR33805
|
SR 33805
|
121345-64-0
|
|
Bradykinin (1-7)
|
舒緩激肽片段1-7
|
23815-87-4
|
|
MK-5046
|
5MG
|
1022152-70-0
|
|
RN486
|
RN 486
|
1242156-23-5
|
|
Spebrutinib
|
AVL292
|
1202757-89-8
|
|
XL228
|
N4-(5-環(huán)丙基-1H-吡唑-3-基)-N2-[[3-異丙基-5-異惡唑基]甲基]-6-(4-甲基-1-哌嗪基)-2,4-嘧啶二胺
|
898280-07-4
|
|
Tirabrutinib
|
替拉魯替尼
|
1351636-18-4
|
|
Orelabrutinib
|
奧布替尼
|
1655504-04-3
|
|
ML230
|
ML233
|
1776055-05-0
|
|
BV02
|
2-(1,5-DIMETHYL-3-OXO-2-PHENYL-2,3-DIHYDRO-1H-PYRAZOL-4-YL)-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID
|
292870-53-2
|
|
NS-638
|
1-[(4-氯苯基)甲基]-5-(三氟甲基)苯并咪唑-2-胺
|
150493-34-8
|
|
TTA-Q6
|
910484-28-5
|
910484-28-5
|
|
PCI 29732
|
4-氨基-1-環(huán)戊基-3-(4-苯氧基苯基)-1H-吡唑并[3,4-D]嘧啶
|
330786-25-9
|
|
Omaveloxolone
|
NRF1-ACTIVATOR-1
|
1474034-05-3
|
|
HUP30
|
N-(6-Nitrobenzo[d]thiazol-2-yl) cyclohexane carboxaMide
|
312747-21-0
|
|
Ibrutinib-biotin
|
1599432-18-4
|
1599432-18-4
|
|
Neuromedin B (porcine)
|
GLY-ASN-LEU-TRP-ALA-THR-GLY-HIS-PHE-MET-NH2
|
87096-84-2
|
|
BODIPY558/568carboxylicacid
|
BODIPY558/568羧酸
|
150173-72-1
|
|
Fantofarone
|
泛托法隆
|
114432-13-2
|
|
Acalabrutinib
|
阿卡替尼
|
1420477-60-6
|
|
Mirogabalin
|
米洛巴林
|
1138245-13-2
|
|
YHO-13351 free base
|
912288-64-3
|
912288-64-3
|
|
Asciminib
|
ABL-001
|
1492952-76-7
|
|
BMS-935177
|
化合物BMS-935177
|
1231889-53-4
|
|
LXH254
|
LXH254
|
1800398-38-2
|
|
BTK inhibitor 10
|
BTK inhibitor 10
|
2241732-30-7
|
|
TAK-020
|
化合物TAK-020
|
1627603-21-7
|
|
Ponatinib-d8
|
納替尼-D8
|
1562993-37-6
|
|
PTC209 HBr
|
PTC-209HBR
|
1217022-63-3
|
|
Ca2+ channel agonist 1
|
1402821-24-2
|
1402821-24-2
|
|
Fenebrutinib
|
GDC-0853
|
1434048-34-6
|
|
BMS-986142
|
BMS986142
|
1643368-58-4
|
|
ACT-709478
|
化合物 T14120
|
1838651-58-3
|
|
SAK3
|
Ethyl 8'-methyl-2',4-dioxo-2-(piperidin-1-yl)-2'H-spiro[cyclopent[2]ene-1,3'-imidazo[1,2-a]pyridine]-3-carboxylate
|
1256269-87-0
|
|
(S)-Nicardipine
|
(S)-Nicardipine
|
76093-36-2
|
|
Pirtobrutinib
|
LOXO-305
|
2101700-15-4
|
|
Ac32Az19
|
化合物 AC32AZ19
|
2760674-72-2
|
|
GNF-5
|
GNF-5
|
778277-15-9
|
|
Acetylcholine-d4 (chloride)
|
氯化乙酰膽堿-D4氘代
|
344298-94-8
|
|
GV-58
|
(2R)-2-[[6-[[(5-甲基噻吩-2-基)甲基]氨基]-9-丙基-9H-嘌呤-2-基]氨基]丁烷-1-醇
|
1402821-41-3
|
|
Nilotinib-d6
|
尼羅替尼-D6
|
1268356-17-7
|
|
Btk inhibitor 2
|
Btk inhibitor 2
|
1558036-85-3
|
|
Des-Arg9]-Bradykinin acetate
|
[DES-ARG9]-緩激肽 乙酸鹽 水合物
|
23827-91-0
|
|
ARQ 531
|
ARQ-531
|
2095393-15-8
|
|
Pinaverium bromide
|
匹維溴銨
|
53251-94-8
|
|
Vecabrutinib
|
維卡布魯替尼
|
1510829-06-7
|
|
BIIB068
|
BIIB068
|
1798787-27-5
|
|
TPC2-A1-N
|
TPC2-A1-N
|
136186-07-7
|
|
TL-895
|
2-Propen-1-one, 1-[4-[[[6-amino-5-(4-phenoxyphenyl)-4-pyrimidinyl]amino]methyl]-4-fluoro-1-piperidinyl]-
|
1415823-49-2
|
|
S116836
|
化合物 T24751
|
1257628-57-1
|
|
Pranidipine
|
普拉地平
|
99522-79-9
|
|
Rebastinib
|
N-[3-叔丁基-1-(喹啉-6-基)-1H-吡唑-5-基]-N'-[2-氟-4-[(2-(甲基氨基甲?；?吡啶-4-基)氧]苯基]脲
|
1020172-07-9
|
|
(±)-Zanubrutinib
|
(±)-贊魯替尼
|
1633350-06-7
|
|
Verapamil
|
維拉帕米
|
52-53-9
|
|
Cinacalcet
|
西那卡塞
|
226256-56-0
|
|
GMB-475
|
GMB-475
|
2490599-18-1
|
|
(Rac)-MEM 1003
|
3,5-Pyridinedicarboxylic acid, 4-(2-chloro-3-cyanophenyl)-1,4-dihydro-2,6-dimethyl-, 3-(2-methoxyethyl) 5-(1-methylethyl) ester
|
165187-25-7
|
|
(S)-Sunvozertinib
|
2-Propenamide, N-[5-[[4-[[5-chloro-4-fluoro-2-(1-hydroxy-1-methylethyl)phenyl]amino]-2-pyrimidinyl]amino]-2-[(3S)-3-(dimethylamino)-1-pyrrolidinyl]-4-methoxyphenyl]-
|
2370013-49-1
|
|
trans-Ned 19
|
化合物 T12205L
|
1354235-96-3
|
|
Bosutinib hydrate
|
博舒替尼一水化合物
|
918639-08-4
|
|
Sunvozertinib
|
DZD 9008
|
2370013-12-8
|
|
Cinacalcet HCl
|
鹽酸甲狀旁腺激素
|
364782-34-3
|
|
Ulixacaltamide
|
N-((1-(2-(叔丁基氨基)-2-氧代乙基)哌啶-4-基)甲基)-3-氯-5-氟苯甲酰胺
|
1199236-64-0
|
|
Mirogabalin besylate
|
10928苯磺酸鹽
|
1138245-21-2
|
|
GSK-7975A
|
1253186-56-9
|
1253186-56-9
|
|
Luxeptinib
|
CG-806
|
1616428-23-9
|
|
Bradykinin (2-9)
|
Bradykinin (2-9)
|
16875-11-9
|
|
BODIPYR6Gcarboxylicacid
|
BODIPYR6G羧酸
|
174881-57-3
|
|
(2R/S)-6-PNG
|
2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-6-(3-methyl-2-buten-1-yl)-4H-1-benzopyran-4-one
|
68682-01-9
|
|
Cav 2.2 blocker 1
|
CAV 2.2 BLOCKER 1
|
1567335-29-8
|
|
SJF620
|
SJF620
|
2376187-16-3
|
|
(R)-Pirtobrutinib
|
(R)-PIRTOBRUTINIB
|
2101700-14-3
|
|
Lys-[Des-Arg9]Bradykinin TFA
|
化合物L(fēng)YS-[DES-ARG9]BRADYKININ,TFA
|
2763588-90-3
|
|
Nicardipine-d3 (hydrochloride)
|
尼卡地平-D3
|
1432061-50-1
|
|
Etiracetam
|
乙拉西坦
|
33996-58-6
|
|
Suvecaltamide
|
MK-8998
|
953778-58-0
|
|
DPH
|
5-(3-(4-氟苯基)-1-苯基-1H-吡唑-4-基)咪唑烷-2,4-二酮
|
484049-04-9
|
|
SB 290157 (trifluoroacetate salt)
|
1140525-25-2
|
1140525-25-2
|
|
Olverembatinib
|
GZD824
|
1257628-77-5
|
|
Olverembatinib dimesylate
|
GZD824DIMESYLATE
|
1421783-64-3
|
|
Dihydrodiol-Ibrutinib
|
依魯替尼代謝物
|
1654820-87-7
|
|
BDP TMR NHS ester
|
BODIPYTMRNHS活化酯
|
485397-12-4
|
|
Branebrutinib
|
BMS-986195
|
1912445-55-6
|
|
Bradykinin (1-5)
|
ARG-PRO-PRO-GLY-PHE
|
23815-89-6
|
|
BODIPYFLcarboxylicacid
|
BODIPYFL羧酸
|
165599-63-3
|
|
BODIPY564/570carboxylicacid
|
BODIPY564/570羧酸
|
150173-89-0
|
|
Drotaverine hydrochloride
|
鹽酸屈他維林
|
985-12-6
|
|
Bafetinib
|
巴氟替尼
|
859212-16-1
|
|
Carboxyamidotriazole Orotate
|
CARBOXYAMIDOTRIAZOLE OROTATE
|
187739-60-2
|
|
BODIPYFLNHSester
|
BODIPYFLNHS活化酯
|
146616-66-2
|
|
ONO-4059 analog
|
6-氨基-7,9-二氫-9-[(3S)-1-(1-氧代-2-丙烯-1-基)-3-哌啶基]-7-(4-苯氧基苯基)-8H-嘌呤-8-酮
|
1351635-67-0
|
|
Tirabrutinib hydrochloride
|
ONO-4059 (HYDROCHLORIDE)
|
1439901-97-9
|
|
Zanubrutinib
|
澤布替尼
|
1691249-45-2
|
|
BODIPY558/568NHSester
|
BODIPY558/568NHS活化酯
|
150173-73-2
|
|
(S)-ML753286
|
1699720-85-8
|
1699720-85-8
|
|
TTA-Q6(isomer)
|
TTA-Q6(isomer)
|
910484-32-1
|
|
Asciminib hydrochloride
|
阿思尼布鹽酸鹽
|
2119669-71-3
|
|
BIIB091
|
1H-1,2,3-TRIAZOLE-4-CARBOXAMIDE, 1-(1,1-DIMETHYLETHYL)-N-[(5R)-2,3,4,5-TETRAHYDRO-8-[2-[(1-METHYL-1H-PYRAZOL-4-YL)AMINO]-4-PYRIMIDINYL]-2-(3-OXETANYL)-1H-2-BENZ
|
2247614-80-6
|
|
Elacridar
|
依克立達(dá)
|
143664-11-3
|